Evidence map›Paper›PMID 23481390›Full record

ArticleNature communications2013

The transcriptional repressor NKAP is required for the development of iNKT cells.

Puspa Thapa, Joy Das, Douglas McWilliams, Michael Shapiro, Rhianna Sundsbak, Molly Nelson-Holte, Sarah Tangen, Joshua Anderson, Stephen Desiderio, Scott Hiebert and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Nature communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Genetic Analysis of iNKT Cell Development and Function.Methods in molecular biology (Clifton, N.J.) · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. NKAP alters tumor immune microenvironment and promotes glioma growth via Notch1 signaling.Journal of experimental & clinical cancer research : CR · 2019
    Article
  10. The Role of the Thymus in the Immune Response.Thoracic surgery clinics · 2019
    Review
  11. Article
  12. Review
  13. Article
  14. Histone deacetylase function in CD4Nature reviews. Immunology · 2018
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Deacetylase activity of histone deacetylase 3 is required for productiveProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Puspa ThapaDepartment of Immunology, Mayo Clinic, 4-14 Guggenheim Building, 200 First Street SW, Rochester, Minnesota 55905, USA.
Joy Das
Douglas McWilliams
Michael Shapiro
Rhianna Sundsbak
Molly Nelson-Holte
Sarah Tangen
Joshua Anderson
Stephen Desiderio
Scott Hiebert
Derek B Sant'angelo
Virginia Smith Shapiro
Mayo Clinic · USRutgers, The State University of New Jersey · USJohns Hopkins University · USVanderbilt University · US

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Chang S Chan · 1997 to 2026
$94.5M
Hdac3 as a therapeutic target in BCL6-dependent lymphomaR01CA164605 · NCI · VANDERBILT UNIVERSITY · PI HIEBERT, SCOTT W · 2012 to 2022
$3.9M
Immunobiology of NKT cell development and functionR01AI059739 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI SANT'ANGELO, DEREK B. · 2006 to 2010
$2.5M
The function of PLZF in innate T cellsR01AI083988 · NIAID · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI SANT'ANGELO, DEREK B. · 2010 to 2014
$2.2M
Temporal and Spatial Control of V(D)J RecombinationR01CA160256 · NCI · JOHNS HOPKINS UNIVERSITY · PI DESIDERIO, STEPHEN V · 2012 to 2016
$1.8M
Leukocyte subset identification by single cell analysis of BTB-ZF geneR21AI095649 · NIAID · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI SANT'ANGELO, DEREK B. · 2013 to 2014
$437k
The Role for NKAP in iNKT cell developmentR21AI093944 · NIAID · MAYO CLINIC ROCHESTER · PI SHAPIRO, VIRGINIA SMITH · 2011 to 2012
$434k
NCI NIH HHS P30 CA072720NCI NIH HHS R01 CA160256NCI NIH HHS R01 CA164605NIAID NIH HHS AI059739NIAID NIH HHS R01 AI059739NIAID NIH HHS R01 AI083988NIAID NIH HHS R21 AI093944NIAID NIH HHS R21 AI095649
6 · The paper itself

Abstract

Invariant natural killer T cells have a distinct developmental pathway from conventional αβ T cells. Here we demonstrate that the transcriptional repressor NKAP is required for invariant natural killer T cell but not conventional T cell development. In CD4-cre NKAP conditional knockout mice, invariant natural killer T cell development is blocked at the double-positive stage. This cell-intrinsic block is not due to decreased survival or failure to rearrange the invariant Vα14-Jα18 T cell receptor-α chain, but is rescued by overexpression of a rec-Vα14-Jα18 transgene at the double-positive stage, thus defining a role for NKAP in selection into the invariant natural killer T cell lineage. Importantly, deletion of the NKAP-associated protein histone deacetylase 3 causes a similar block in the invariant natural killer T cell development, indicating that NKAP and histone deacetylase 3 functionally interact to control invariant natural killer T cell development.

Indexed as

AnimalsCell SurvivalGene DeletionGene Rearrangement, alpha-Chain T-Cell Antigen ReceptorHistone Deacetylase 3Histone DeacetylasesMiceMice, KnockoutNatural Killer T-CellsOrgan SpecificityReceptors, Antigen, T-Cell, alpha-betaReceptors, NotchRecombination, GeneticRepressor ProteinsThymocytesHistone Deacetylase 3Histone DeacetylasesNKAP protein, mouseReceptors, Antigen, T-Cell, alpha-betaReceptors, NotchRepressor Proteins

Identifiers

PMID23481390
PMCPMC3615467
OpenAlexW2032599105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.